CoChat
Sign Up
Cited by 36

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

N-trimethyl chitosan coated nano-complexes enhance the oral bioavailability and chemotherapeutic effects of gemcitabine

Chen, Guanyu, Svirskis, Darren, Lu, Weiyue, Ying, Man, Li, Hongyu, Liu, Min, Wen, Jingyuan·2021·Carbohydrate Polymers
DOI 10.1016/j.carbpol.2021.118592
Open this paper in CoChat — free account

Abstract

N-trimethyl chitosan (TMC) is a multifunctional polymer that can be used in various nanoparticle forms in the pharmaceutical, nutraceutical and biomedical fields. In this study, TMC was used as a mucoadhesive adjuvant to enhance the oral bioavailability and hence antitumour effects of gemcitabine formulated into nanocomplexes composed of poly(lactic-co-glycolic acid) nanoparticles (PLGA NPs) conjugated with d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS). A central composite design was applied to achieve the optimal formulation. Cellular uptake and drug transportation studies revealed the nanocomplexes permeate over the intestinal cells via adsorptive-mediated and caveolae-mediated endocytosis. Pharmacokinetic studies demonstrated the oral drug bioavailability of the nanocomplexes was increased 5.1-fold compared with drug solution. In pharmacodynamic studies, the formulation reduced tumour size 3.1-fold compared with the drug solution. The data demonstrates that TMC modified nanocomplexes can enhance gemcitabine oral bioavailability and promote the anticancer efficacy.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.carbpol.2021.118592

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 1 references

Research works printed but not linked: 68

  1. Acharya, 2011, PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect, Advanced Drug Delivery Reviews, 63, 170, 10.1016/j.addr.2010.10.008 · DOI
  2. Agnihotri, 2004, Recent advances on chitosan-based micro- and nanoparticles in drug delivery, Journal of Controlled Release, 100, 5, 10.1016/j.jconrel.2004.08.010 · DOI
  3. Ahmad, 2018, Enhancement of oral bioavailability of doxorubicin through surface modified biodegradable polymeric nanoparticles, Chemistry Central Journal, 12, 1, 10.1186/s13065-018-0434-1 · DOI
  4. Ahmad, 2018, Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations, Journal of Microencapsulation, 35, 327, 10.1080/02652048.2018.1485755 · DOI
  5. Amidi, 2006, Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system, Journal of Controlled Release, 111, 107, 10.1016/j.jconrel.2005.11.014 · DOI
  6. Anwer, 2017, Preparation, evaluation and bioavailability studies of eudragit coated PLGA nanoparticles for sustained release of eluxadoline for the treatment of irritable bowel syndrome, Frontiers in Pharmacology, 8, 844, 10.3389/fphar.2017.00844 · DOI
  7. Arafa, 2020, Chitosan-coated PLGA nanoparticles for enhanced ocular anti-inflammatory efficacy of atorvastatin calcium, International Journal of Nanomedicine, 15, 1335, 10.2147/IJN.S237314 · DOI
  8. Bandi, 2020, Effect of particle size and surface charge of nanoparticles in penetration through intestinal mucus barrier, Journal of Nanoparticle Research, 22, 1, 10.1007/s11051-020-04785-y · DOI
  9. Behrens, 2002, Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: The effect of mucus on particle adsorption and transport, Pharmaceutical Research, 19, 1185, 10.1023/A:1019854327540 · DOI
  10. Bensaid, 2013, Y-shaped mPEG-PLA cabazitaxel conjugates: Well-controlled synthesis by organocatalytic approach and self-assembly into interface drug-loaded core–corona nanoparticles, Biomacromolecules, 14, 1189, 10.1021/bm400161g · DOI
  11. Budhian, 2007, Haloperidol-loaded PLGA nanoparticles: Systematic study of particle size and drug content, International Journal of Pharmaceutics, 336, 367, 10.1016/j.ijpharm.2006.11.061 · DOI
  12. Cacua, 2019, Surfactant concentration and pH effects on the zeta potential values of alumina nanofluids to inspect stability, Colloids and Surfaces A: Physicochemical and Engineering Aspects, 583, 10.1016/j.colsurfa.2019.123960 · DOI
  13. Cavaliere, 2017, Fluorinated nucleosides as an important class of anticancer and antiviral agents, Future Medicinal Chemistry, 9, 1809, 10.4155/fmc-2017-0095 · DOI
  14. Chen, 2015, Mucoadhesive polymers-based film as a carrier system for sublingual delivery of glutathione, Journal of Pharmacy and Pharmacology, 67, 26, 10.1111/jphp.12313 · DOI
  15. Chen, 2018, N-trimethyl chitosan nanoparticles and CSKSSDYQC peptide: N-trimethyl chitosan conjugates enhance the oral bioavailability of gemcitabine to treat breast cancer, Journal of Controlled Release, 277, 142, 10.1016/j.jconrel.2018.03.013 · DOI
  16. Chen, 2015, Development and validation of a stability indicating isocratic HPLC method for gemcitabine with application to drug release from poly lactic-co-glycolic acid nanoparticles and enzymatic degradation studies, Journal of Pharmacy and Pharmacology, 67, 1528, 10.1111/jphp.12470 · DOI
  17. Chen, 2018, Poly (lactic-co-glycolic acid) based double emulsion nanoparticle as a carrier system to deliver glutathione sublingually, Journal of Biomedical, 3, 50, 10.7150/jbm.27148 · DOI
  18. de Oliveira Pedro, 2018, Self-assembled amphiphilic chitosan nanoparticles for quercetin delivery to breast cancer cells, European Journal of Pharmaceutics and Biopharmaceutics, 131, 203, 10.1016/j.ejpb.2018.08.009 · DOI
  19. de Sousa Cavalcante, 2014, Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer, European Journal of Pharmacology, 741, 8, 10.1016/j.ejphar.2014.07.041 · DOI
  20. Erlij, 1972, Opening of tight junctions in frog skin by hypertonic urea solutions, The Journal of Membrane Biology, 9, 229, 10.1007/BF01868054 · DOI
  21. Florence, 1993, Particulate delivery: The challenge of the oral route, Drugs and the Pharmaceutical Sciences, 61, 65
  22. Foster, 2001, Microparticulate uptake mechanisms of in-vitro cell culture models of the respiratory epithelium, Journal of Pharmacy and Pharmacology, 53, 57, 10.1211/0022357011775190 · DOI
  23. Fotakis, 2006, In vitro cytotoxicity assays: Comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride, Toxicology Letters, 160, 171, 10.1016/j.toxlet.2005.07.001 · DOI
  24. Galindo-Rodriguez, 2005, Polymeric nanoparticles for oral delivery of drugs and vaccines: A critical evaluation of in vivo studies, Critical ReviewsTM in Therapeutic Drug Carrier Systems, 22
  25. González, 1993, Optimization of pharmaceutical formulations based on response-surface experimental designs, International Journal of Pharmaceutics, 97, 149, 10.1016/0378-5173(93)90135-3 · DOI
  26. Grès, 1998, Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: Comparison with the parental Caco-2 cell line, Pharmaceutical Research, 15, 726, 10.1023/A:1011919003030 · DOI
  27. Hilgendorf, 2000, Caco-2 versus caco-2/HT29-MTX co-cultured cell lines: Permeabilities via diffusion, inside-and outside-directed carrier-mediated transport, Journal of Pharmaceutical Sciences, 89, 63, 10.1002/(SICI)1520-6017(200001)89:1<63::AID-JPS7>3.0.CO;2-6 · DOI
  28. Ho, 1997, Role of heparan sulfate proteoglycans in the uptake and degradation of tissue factor pathway inhibitor-coagulation factor Xa complexes, Journal of Biological Chemistry, 272, 16838, 10.1074/jbc.272.27.16838 · DOI
  29. Hu, 2006, Effects of genetic polymorphisms of CYP3A4, CYP3A5 and MDR1 on cyclosporine pharmacokinetics after renal transplantation, Clinical and Experimental Pharmacology and Physiology, 33, 1093, 10.1111/j.1440-1681.2006.04492.x · DOI
  30. Huang, 2002, Uptake of FITC-chitosan nanoparticles by A549 cells, Pharmaceutical Research, 19, 1488, 10.1023/A:1020404615898 · DOI
  31. Huo, 2019, Effect of zeta potential on properties of foamed colloidal suspension, Journal of the European Ceramic Society, 39, 574, 10.1016/j.jeurceramsoc.2018.08.035 · DOI
  32. Hussain, 2009, Clove (Syzygium aromaticum) extract potentiates gemcitabine cytotoxic effect on human cervical cancer cell line, International Journal of Cancer Research, 5, 95, 10.3923/ijcr.2009.95.104 · DOI
  33. Jain, 2000, The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide)(PLGA) devices, Biomaterials, 21, 2475, 10.1016/S0142-9612(00)00115-0 · DOI · Paper page
  34. Jin, 2012, Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport, Biomaterials, 33, 1573, 10.1016/j.biomaterials.2011.10.075 · DOI · Paper page
  35. Joshi, 2014, Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery, European Journal of Pharmaceutical Sciences, 60, 80, 10.1016/j.ejps.2014.04.014 · DOI
  36. Kotzé, 1998, Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2), Journal of Controlled Release, 51, 35, 10.1016/S0168-3659(97)00154-5 · DOI · Paper page
  37. Kumar, 2004, Preparation and characterization of cationic PLGA nanospheres as DNA carriers, Biomaterials, 25, 1771, 10.1016/j.biomaterials.2003.08.069 · DOI
  38. Kumari, 2010, Biodegradable polymeric nanoparticles based drug delivery systems, Colloids and Surfaces B: Biointerfaces, 75, 1, 10.1016/j.colsurfb.2009.09.001 · DOI
  39. Leonard, 2004, Hydrophobically modified alginate hydrogels as protein carriers with specific controlled release properties, Journal of Controlled Release, 98, 395, 10.1016/j.jconrel.2004.05.009 · DOI
  40. Li, 2018, Histology of geographic atrophy secondary to age-related macular degeneration: A multilayer approach, Retina (Philadelphia, Pa.), 38, 1937, 10.1097/IAE.0000000000002182 · DOI
  41. Li, 2017, The studies of PLGA nanoparticles loading atorvastatin calcium for oral administration in vitro and in vivo, Asian Journal of Pharmaceutical Sciences, 12, 285, 10.1016/j.ajps.2016.08.006 · DOI
  42. Liu, 2016, Multi-drug loaded vitamin E-TPGS nanoparticles for synergistic drug delivery to overcome drug resistance in tumor treatment, Science Bulletin, 61, 552, 10.1007/s11434-016-1039-5 · DOI
  43. Ma, 2010, Nanoparticles of poly (lactide-co-glycolide)-da-tocopheryl polyethylene glycol 1000 succinate random copolymer for cancer treatment, Nanoscale Research Letters, 5, 1161, 10.1007/s11671-010-9620-3 · DOI
  44. Maa, 2000, Biopharmaceutical powders particle formation and formulation considerations, Current Pharmaceutical Biotechnology, 1, 283, 10.2174/1389201003378898 · DOI
  45. Matsson, 2009, Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs, Pharmaceutical Research, 26, 1816, 10.1007/s11095-009-9896-0 · DOI
  46. Mourya, 2009, Trimethyl chitosan and its applications in drug delivery, Journal of Materials Science: Materials in Medicine, 20, 1057
  47. Musumeci, 2006, PLA/PLGA nanoparticles for sustained release of docetaxel, International Journal of Pharmaceutics, 325, 172, 10.1016/j.ijpharm.2006.06.023 · DOI
  48. Naserifar, 2020, Oral delivery of folate-targeted resveratrol-loaded nanoparticles for inflammatory bowel disease therapy in rats, Life Sciences, 262, 10.1016/j.lfs.2020.118555 · DOI
  49. Pandey, 2005, Oral solid lipid nanoparticle-based antitubercular chemotherapy, Tuberculosis, 85, 415, 10.1016/j.tube.2005.08.009 · DOI · Paper page
  50. Parveen, 2008, Polymeric nanoparticles for cancer therapy, Journal of Drug Targeting, 16, 108, 10.1080/10611860701794353 · DOI
  51. Pradhan, 2013, Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: Formulation, physicochemical characterization and cytotoxicity studies, Journal of Nanoscience and Nanotechnology, 13, 5948, 10.1166/jnn.2013.7735 · DOI
  52. Qiao, 2005, Injectable biodegradable temperature-responsive PLGA–PEG–PLGA copolymers: Synthesis and effect of copolymer composition on the drug release from the copolymer-based hydrogels, International Journal of Pharmaceutics, 294, 103, 10.1016/j.ijpharm.2005.01.017 · DOI
  53. Ramos Yacasi, 2017, Freeze drying optimization of polymeric nanoparticles for ocular flurbiprofen delivery: Effect of protectant agents and critical process parameters on long-term stability, Drug Development and Industrial Pharmacy, 43, 637, 10.1080/03639045.2016.1275669 · DOI
  54. Sai, 1998, Adsorptive-mediated endocytosis of a basic peptide in enterocyte-like Caco-2 cells, American Journal of Physiology-Gastrointestinal and Liver Physiology, 275, G514, 10.1152/ajpgi.1998.275.3.G514 · DOI
  55. Saif, 2007, Gemcitabine-induced liver fibrosis in a patient with pancreatic cancer, Jop, 8, 460
  56. Song, 2011, Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery, Colloids and Surfaces B: Biointerfaces, 87, 454, 10.1016/j.colsurfb.2011.06.009 · DOI
  57. Song, 2008, Dual agents loaded PLGA nanoparticles: Systematic study of particle size and drug entrapment efficiency, European Journal of Pharmaceutics and Biopharmaceutics, 69, 445, 10.1016/j.ejpb.2008.01.013 · DOI
  58. Summers, 2004, Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy, Annals of Pharmacotherapy, 38, 1631, 10.1345/aph.1E068 · DOI
  59. Sun, 2021, Galactosamine-modified PEG-PLA/TPGS micelles for the oral delivery of curcumin, International Journal of Pharmaceutics, 595, 10.1016/j.ijpharm.2021.120227 · DOI
  60. Tomita, 1996, Absorption-enhancing mechanism of EDTA, caprate, and decanoylcarnitine in Caco-2 cells, Journal of Pharmaceutical Sciences, 85, 608, 10.1021/js9504604 · DOI
  61. Vllasaliu, 2010, Tight junction modulation by chitosan nanoparticles: Comparison with chitosan solution, International Journal of Pharmaceutics, 400, 183, 10.1016/j.ijpharm.2010.08.020 · DOI
  62. Walgren, 2000, Cellular uptake of dietary flavonoid quercetin 4′-β-glucoside by sodium-dependent glucose transporter SGLT1, Journal of Pharmacology and Experimental Therapeutics, 294, 837, 10.1016/S0022-3565(24)39143-8 · DOI
  63. Wang, 2011, Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel-polymer micelles to overcome multi-drug resistance, Biomaterials, 32, 9444, 10.1016/j.biomaterials.2011.08.041 · DOI
  64. Wei, 2013, Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy, Acta Biomaterialia, 9, 8910, 10.1016/j.actbio.2013.06.034 · DOI
  65. Youdim, 2003, In vitro trans-monolayer permeability calculations: Often forgotten assumptions, Drug Discovery Today, 8, 997, 10.1016/S1359-6446(03)02873-3 · DOI
  66. Yu, 2011, Biodegradable polymer microcapsules fabrication through a template-free approach, Langmuir, 27, 10265, 10.1021/la201944s · DOI
  67. Yun, 2013, Nanoparticles for oral delivery: Targeted nanoparticles with peptidic ligands for oral protein delivery, Advanced Drug Delivery Reviews, 65, 822, 10.1016/j.addr.2012.10.007 · DOI
  68. Zambito, 2006, Effects of N-trimethylchitosan on transcellular and paracellular transcorneal drug transport, European Journal of Pharmaceutics and Biopharmaceutics, 64, 16, 10.1016/j.ejpb.2006.01.004 · DOI

Cited by

Sorted by citations

Metadata

Authors
Chen, G., Svirskis, D., Lu, W., Ying, M., Li, H., Liu, M., & Wen, J.
Venue
Carbohydrate Polymers
Publisher
Elsevier BV
Published
2021-12
Volume
273
Pages
118592
ISSN
0144-8617
DOI
10.1016/j.carbpol.2021.118592
Cited by
36
References
1
Language
en
Licence
Funders
  • University of Auckland
  • Fudan University

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review